Sale!

DYNC1H1 Gene Charcot-Marie-Tooth Disease Axonal Type 20 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DYNC1H1 gene plays a critical role in the development and function of the peripheral nervous system. Mutations in this gene are associated with Charcot-Marie-Tooth disease axonal type 20 (CMT2O), a form of hereditary motor and sensory neuropathy. This condition is characterized by a progressive loss of muscle tissue and touch sensation across various parts of the body. The genetic test for CMT2O involves analyzing the DYNC1H1 gene to identify mutations that cause the disease. This testing is crucial for confirming the diagnosis, understanding the disease progression, and making informed decisions about management and treatment.

At DNA Labs UAE, the test for identifying DYNC1H1 gene mutations associated with Charcot-Marie-Tooth disease axonal type 20 is available. The cost of the test is 4400 AED. Conducted in a state-of-the-art laboratory by experienced geneticists, the test provides accurate and reliable results, offering crucial information for affected individuals and their families. Through this testing, it becomes possible to adopt a proactive approach in managing the condition, including early intervention strategies and genetic counseling for family planning.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DYNC1H1 Gene Charcot-Marie-Tooth disease axonal type 20 Genetic Test

Test Details

The DYNC1H1 gene is associated with Charcot-Marie-Tooth disease, axonal type 20. This genetic test is performed using Next Generation Sequencing (NGS) technology to detect variations in the DYNC1H1 gene that may cause the disease.

Charcot-Marie-Tooth disease is a group of inherited disorders that affect the peripheral nerves, causing muscle weakness and wasting in the feet, legs, hands, and forearms. Axonal type 20 is a subtype of Charcot-Marie-Tooth disease that specifically affects the axons, which are the long fibers that transmit nerve impulses.

The NGS genetic test for the DYNC1H1 gene can help diagnose the disease and guide appropriate treatment and management strategies.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the DYNC1H1 Gene Charcot-Marie-Tooth disease axonal type 20 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session may be conducted to draw a pedigree chart of family members affected with the disease.

Test Name DYNC1H1 Gene Charcot-Marie-Tooth disease axonal type 20 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DYNC1H1 Gene Charcot-Marie-Tooth disease, axonal type 20 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DYNC1H1 Gene Charcot-Marie-Tooth disease, axonal type 20
Test Details

DYNC1H1 gene is associated with Charcot-Marie-Tooth disease, axonal type 20. This genetic test is performed using Next Generation Sequencing (NGS) technology to detect variations in the DYNC1H1 gene that may cause the disease. Charcot-Marie-Tooth disease is a group of inherited disorders that affect the peripheral nerves, causing muscle weakness and wasting in the feet, legs, hands, and forearms. Axonal type 20 is a subtype of Charcot-Marie-Tooth disease that affects the axons, which are the long fibers that transmit nerve impulses. The NGS genetic test for DYNC1H1 gene can help diagnose the disease and guide appropriate treatment and management strategies.